Global Health Ltd

Global Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Global Health Ltd

₹ 1,415 -0.65%
03 May 2:41 p.m.
medanta.org BSE: 543654 NSE : MEDANTA
About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Key Points

** Hospital Count**[1] Global Health has 5 hospitals in operation (Gurugram, Indore, Ranchi, Lucknow, and Patna), and 1 hospital under construction (Noida) under the ‘’Medanta’’ Brand.
Company provides healthcare services in 30+ medical specialties and engages 1,300+ doctors, spanning an area of 4.7 msf.
Operational hospitals have 2,467 installed beds.
They also operate 6 multi-specialty clinics at DLF Cybercity Gurugram, Delhi Airport, south Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]

Website BSE NSE
  • Market Cap ₹ 37,998 Cr.
  • Current Price ₹ 1,415
  • High / Low ₹ 1,514 / 496
  • Stock P/E 109
  • Book Value ₹ 99.4
  • Dividend Yield 0.00 %
  • ROCE 15.9 %
  • ROE 12.5 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 47.8% CAGR over last 5 years

Cons

  • Stock is trading at 14.0 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 7.84% over past five years.
  • Company has a low return on equity of 10.4% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
467 411 473 494 490 503 545 580 562
356 344 372 391 394 400 435 452 439
Operating Profit 111 67 101 103 95 103 109 128 123
OPM % 24% 16% 21% 21% 19% 20% 20% 22% 22%
8 12 8 13 13 28 33 26 26
Interest 7 6 7 7 6 6 6 6 6
Depreciation 22 22 22 22 22 20 20 22 22
Profit before tax 90 51 80 87 80 104 116 127 121
Tax % 24% 25% 27% 25% 26% 22% 26% 25% 28%
68 38 58 65 59 81 86 95 87
EPS in Rs 2.69 1.50 2.30 2.58 2.19 3.02 3.21 3.54 3.25
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,277 1,343 1,441 1,472 1,227 1,765 1,959 2,189
1,158 1,218 1,297 1,253 1,054 1,384 1,551 1,726
Operating Profit 119 125 144 219 173 381 409 463
OPM % 9% 9% 10% 15% 14% 22% 21% 21%
67 49 64 43 28 35 61 113
Interest 19 24 21 33 29 33 32 25
Depreciation 77 86 91 99 88 87 86 84
Profit before tax 89 64 97 131 84 296 352 468
Tax % 39% 42% 35% 22% 32% 26% 25%
54 37 63 103 57 219 263 350
EPS in Rs 11.21 7.70 12.81 20.82 11.55 8.64 9.82 13.02
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 8%
3 Years: 10%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 48%
3 Years: 37%
TTM: 59%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 177%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 10%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 48 81 49 49 50 51 54 54
Reserves 1,070 1,141 1,230 1,341 1,434 1,689 2,435 2,615
Preference Capital 32 0 32 32 0 0 0
183 168 136 19 228 308 288 248
335 318 343 549 291 314 402 438
Total Liabilities 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,355
966 1,162 869 929 851 827 810 804
CWIP 8 7 5 3 4 6 75 106
Investments 21 0 356 500 626 734 765 790
642 540 528 525 521 794 1,529 1,655
Total Assets 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,355

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
124 152 193 201 235 431
-112 -104 -45 -250 -313 -257
-6 -49 -56 -37 98 404
Net Cash Flow 6 -1 92 -86 20 577

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 31 41 42 37 39 36 32
Inventory Days 36 26 26 37 39 33 33
Days Payable 132 124 142 135 134 84 112
Cash Conversion Cycle -66 -56 -74 -61 -56 -16 -46
Working Capital Days -23 -4 -7 -11 -10 8 -13
ROCE % 6% 8% 11% 7% 17% 16%

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
33.08% 33.08% 33.07% 33.06% 33.05% 33.04%
9.36% 9.89% 10.58% 10.69% 11.36% 12.10%
12.55% 12.34% 10.79% 10.93% 11.15% 10.25%
45.01% 44.67% 45.55% 45.31% 44.45% 44.60%
No. of Shareholders 1,21,4071,07,1201,09,7981,16,6271,24,7751,66,253

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls